Diabetes Mellitus Type 2NCT07245082
Patients With Type 2 Diabetes
An observational study of Diabetes Mellitus Type 2, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
Diabetes mellitus Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes Mellitus Type 2
- How many people
- 2,000 participants
- Where
- 1 siteTaiwan
- Study dates
- 9 Oct 2025to 21 Aug 2028
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.
Who may be able to join
- Adults aged 18 or older.
- Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
- Participants are willing to participate in the study and have signed the consent form.
- Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).
Who cannot join
- Individuals who cannot understand the study content.
- Individuals who cannot cooperate with relevant assessments.
- Other individuals who are clinically deemed unsuitable for participation by the project leader.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
National Taiwan University Hospital
Taipei, Zhongzheng Dist, 100229
About this study
Official title: Cohort Study of Patients With Type 2 Diabetes
Diabetes mellitus
Read the detailed description
This study aims to establish both retrospective and prospective cohorts of patients with type 2 diabetes, enabling long-term follow-up of metabolic factors and related complications (such as cardiovascular disease, nephropathy, and neuropathy), as well as changes in nutritional status and physical function (including dietary habits, body composition, and grip strength). The goal is to identify risk factors that influence clinical outcomes and to provide evidence to support individualized treatment and integrated care strategies.
- Conditions
- Diabetes Mellitus Type 2
- Keywords
- Obesity, Diabetic macular edema, diabetic kidney disease, Diabetic retinopathy, Nutritional status, Physical activity, Peripheral Arterial Occlusive Disease, Body composition, Metabolic Syndrome, Dynapenia
- Medical subject headings
- Diabetes Mellitus, Type 2, Obesity, Diabetic Nephropathies, Diabetic Retinopathy, Motor Activity, Peripheral Arterial Occlusive Disease 1, Metabolic Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Cohort Study of Patients With Type 2 Diabetes | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)
Measured: Everytime after physician's appointment(Usually 3 months).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2025
- Study start9 Oct 2025
- Primary completion21 Aug 2028 (estimated)
- Study completion21 Aug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes Mellitus Type 2Studies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Chia-Wen Lu, Present Professor, Study chair, Department of Family Medicine, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07245082
- Sponsor's protocol ID
- 202507201RINE
- Status last verified
- Sep 2025
- First submitted
- 16 Nov 2025
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cohort Study of Patients With Type 2 Diabetes
- ClinicalTrials.gov ID
- NCT07245082
- Acronym / sponsor ID
- 202507201RINE
- Conditions
- Diabetes Mellitus Type 2
- Keywords
- Obesity, Diabetic macular edema, diabetic kidney disease, Diabetic retinopathy, Nutritional status, Physical activity, Peripheral Arterial Occlusive Disease, Body composition
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 9 Oct 2025 (actual)
- Primary completion
- 21 Aug 2028 (estimated)
- Study completion
- 21 Aug 2028 (estimated)
- First posted
- 24 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Diabetes mellitus
Detailed description
This study aims to establish both retrospective and prospective cohorts of patients with type 2 diabetes, enabling long-term follow-up of metabolic factors and related complications (such as cardiovascular disease, nephropathy, and neuropathy), as well as changes in nutritional status and physical function (including dietary habits, body composition, and grip strength). The goal is to identify risk factors that influence clinical outcomes and to provide evidence to support individualized treatment and integrated care strategies.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 3 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Cohort Study of Patients With Type 2 Diabetes | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.
Key inclusion criteria (4 listed)
- Adults aged 18 or older.
- Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
- Participants are willing to participate in the study and have signed the consent form.
- Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).
Key exclusion criteria (3 listed)
- Individuals who cannot understand the study content.
- Individuals who cannot cooperate with relevant assessments.
- Other individuals who are clinically deemed unsuitable for participation by the project leader.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)
Time frame: Everytime after physician's appointment(Usually 3 months).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Diabetes Mellitus Type 2
Recruiting
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Enrolling by invitation
MTM2MTG Pilot Ancillary Study
Diet, Healthy, HbA1c
Active, not recruiting
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources
PreDiabetes, Diabetes Mellitus, Type 2
Not yet recruitingPhase 1/2
A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
Cochlear Synaptopathy
Not yet recruitingPhase 1
A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chia-Wen Lu, Present Professor study chair
Department of Family Medicine, National Taiwan University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Mellitus Type 2, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chia-Wen Lu, Present Professor (886-2-23123456 ext. 266703, biopsycosocial@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength) (time frame: Everytime after physician's appointment(Usually 3 months).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.